TDMS Study 96021-01 Pathology Tables
NTP STATISTICAL ANALYSIS OF PRIMARY TUMORS REPORT: PEIRPT08
LAB: Battelle Columbus TOXIC EQUIVALENCY FACTOR EVALUATION (PCB 153) DATE: 02/09/04
EXPERIMENT: 96021 TEST: 01 TIME: 10:11:12
TEST TYPE: CHRONIC CAGES FROM 0000 TO LAST CAGE
CONT: NO1-ES-75411 ROUTE: GAVAGE NTP C#: C96021
PATHOLOGIST: SELLS, DONALD CAS: 35065-27-1
Rats(SPRAGUE-DAWLEY)
-----------------------------
FOR ALL DOSES THE TUMOR RATES IN THE FOLLOWING TISSUES/ORGANS ARE
BASED ON NUMBER OF TISSUES EXAMINED. IN OTHER TISSUES/ORGANS RATES
ARE BASED ON THE NUMBER OF ANIMALS NECROPSIED.
---------------
Adrenal Cortex
Adrenal Medulla
Bone Marrow
Brain
Clitoral/Preputial Gland
Heart
Islets, Pancreatic
Kidney
Liver
Lung
Ovary
Pancreas
Parathyroid Gland
Pituitary Gland
Thyroid Gland
NTP STATISTICAL ANALYSIS OF PRIMARY TUMORS REPORT: PEIRPT08
LAB: Battelle Columbus TOXIC EQUIVALENCY FACTOR EVALUATION (PCB 153) DATE: 02/09/04
EXPERIMENT: 96021 TEST: 01 TIME: 10:11:12
TEST TYPE: CHRONIC CAGES FROM 0000 TO LAST CAGE
CONT: NO1-ES-75411 ROUTE: GAVAGE NTP C#: C96021
PATHOLOGIST: SELLS, DONALD CAS: 35065-27-1
SUMMARY OF STATISTICALLY SIGNIFICANT (P<=.05) RESULTS
IN THE ANALYSIS OF TOXIC EQUIVALENCY FACTOR EVALUATION (
===============================================================
Female Rats
------------
Organ Morphology
----- ----------
Adrenal Medulla Pheochromocytoma Benign
Pheochromocytoma: Benign, Complex, Malignant, NOS
Islets, Pancreatic Carcinoma or Adenoma
Liver Cholangioma
Mammary Gland Adenoma
Carcinoma
Carcinoma or Adenoma
Fibroadenoma
Fibroma, Fibroadenoma or Adenoma
Fibroma, Fibroadenoma, Carcinoma, or Adenoma
Pituitary Gland: Pars Distalis or Unspecified Site
Adenoma
Carcinoma or Adenoma
Skin Fibroma
Fibroma, Fibrosarcoma, Sarcoma, Myxoma, Myxosarcoma, or Fibrous Histiocytoma
Fibrosarcoma
Fibrosarcoma, Sarcoma, Myxosarcoma, or Fibrous Histiocytoma
Thyroid Gland: C-Cell Adenoma
Carcinoma
Carcinoma or Adenoma
Thyroid Gland: Follicular Cell Adenoma
Uterus Polyp Stromal
Vagina Schwannoma Malignant
All Organs Benign Tumors
Malignant Tumors
Malignant and Benign Tumors
===============================================================
Date: 02/09/04 EXPERIMENT: 96021 TEST: 01 Page 1
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 105 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|Adrenal Medulla |
| Pheochromocytoma Benign |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 6/50 (12%) 3/51 (6%) |
|POLY-3 RATE (b) | 6/37.40 3/33.81 |
|POLY-3 PERCENT (g) | 16.0% 8.9% |
|TERMINAL (d) | 2/20 (10%) 1/21 (5%) |
|FIRST INCIDENCE | 591 586 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.297N |
|POLY 3 | P=0.297N |
|POLY 1.5 | P=0.266N |
|POLY 6 | P=0.328N |
|LOGISTIC REGRESSION| P=0.280N |
|COCH-ARM / FISHERS | P=0.234N |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|Adrenal Medulla |
| Pheochromocytoma: Benign, Complex, Malignant, NOS |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 6/50 (12%) 3/51 (6%) |
|POLY-3 RATE (b) | 6/37.40 3/33.81 |
|POLY-3 PERCENT (g) | 16.0% 8.9% |
|TERMINAL (d) | 2/20 (10%) 1/21 (5%) |
|FIRST INCIDENCE | 591 586 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.297N |
|POLY 3 | P=0.297N |
|POLY 1.5 | P=0.266N |
|POLY 6 | P=0.328N |
|LOGISTIC REGRESSION| P=0.280N |
|COCH-ARM / FISHERS | P=0.234N |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
Date: 02/09/04 EXPERIMENT: 96021 TEST: 01 Page 2
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 105 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|Islets, Pancreatic |
| Carcinoma or Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 2/50 (4%) 0/51 (0%) |
|POLY-3 RATE (b) | 2/36.65 0/33.11 |
|POLY-3 PERCENT (g) | 5.5% 0.0% |
|TERMINAL (d) | 1/20 (5%) 0/21 (0%) |
|FIRST INCIDENCE | 656 --- |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.258N |
|POLY 3 | P=0.273N |
|POLY 1.5 | P=0.253N |
|POLY 6 | P=0.294N |
|LOGISTIC REGRESSION| P=0.262N |
|COCH-ARM / FISHERS | P=0.243N |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|Liver |
| Cholangioma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 2/50 (4%) 0/51 (0%) |
|POLY-3 RATE (b) | 2/36.38 0/33.11 |
|POLY-3 PERCENT (g) | 5.5% 0.0% |
|TERMINAL (d) | 2/20 (10%) 0/21 (0%) |
|FIRST INCIDENCE | 731 (T) --- |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.226N |
|POLY 3 | P=0.270N |
|POLY 1.5 | P=0.252N |
|POLY 6 | P=0.288N |
|LOGISTIC REGRESSION| (e) |
|COCH-ARM / FISHERS | P=0.243N |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
Date: 02/09/04 EXPERIMENT: 96021 TEST: 01 Page 3
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 105 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|Mammary Gland |
| Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # |
|----------- | |
|OVERALL (a) | 0/50 (0%) 2/51 (4%) |
|POLY-3 RATE (b) | 0/36.38 2/33.52 |
|POLY-3 PERCENT (g) | 0.0% 6.0% |
|TERMINAL (d) | 0/20 (0%) 1/21 (5%) |
|FIRST INCIDENCE | --- 612 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.224 |
|POLY 3 | P=0.228 |
|POLY 1.5 | P=0.233 |
|POLY 6 | P=0.225 |
|LOGISTIC REGRESSION| P=0.221 |
|COCH-ARM / FISHERS | P=0.252 |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|Mammary Gland |
| Carcinoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # |
|----------- | |
|OVERALL (a) | 10/50 (20%) 2/51 (4%) |
|POLY-3 RATE (b) | 10/38.41 2/34.52 |
|POLY-3 PERCENT (g) | 26.0% 5.8% |
|TERMINAL (d) | 4/20 (20%) 0/21 (0%) |
|FIRST INCIDENCE | 245 79 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.026N* |
|POLY 3 | P=0.020N* |
|POLY 1.5 | P=0.016N* |
|POLY 6 | P=0.026N* |
|LOGISTIC REGRESSION| P=0.013N* |
|COCH-ARM / FISHERS | P=0.013N* |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
Date: 02/09/04 EXPERIMENT: 96021 TEST: 01 Page 4
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 105 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|Mammary Gland |
| Carcinoma or Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # |
|----------- | |
|OVERALL (a) | 10/50 (20%) 3/51 (6%) |
|POLY-3 RATE (b) | 10/38.41 3/34.52 |
|POLY-3 PERCENT (g) | 26.0% 8.7% |
|TERMINAL (d) | 4/20 (20%) 1/21 (5%) |
|FIRST INCIDENCE | 245 79 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.055N |
|POLY 3 | P=0.051N |
|POLY 1.5 | P=0.040N* |
|POLY 6 | P=0.063N |
|LOGISTIC REGRESSION| P=0.033N* |
|COCH-ARM / FISHERS | P=0.033N* |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|Mammary Gland |
| Fibroadenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # |
|----------- | |
|OVERALL (a) | 30/50 (60%) 32/51 (63%) |
|POLY-3 RATE (b) | 30/43.00 32/44.62 |
|POLY-3 PERCENT (g) | 69.8% 71.7% |
|TERMINAL (d) | 11/20 (55%) 13/21 (62%) |
|FIRST INCIDENCE | 360 360 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.349 |
|POLY 3 | P=0.513 |
|POLY 1.5 | P=0.516 |
|POLY 6 | P=0.487 |
|LOGISTIC REGRESSION| P=0.418 |
|COCH-ARM / FISHERS | P=0.469 |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
Date: 02/09/04 EXPERIMENT: 96021 TEST: 01 Page 5
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 105 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|Mammary Gland |
| Fibroma, Fibroadenoma or Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # |
|----------- | |
|OVERALL (a) | 30/50 (60%) 33/51 (65%) |
|POLY-3 RATE (b) | 30/43.00 33/44.62 |
|POLY-3 PERCENT (g) | 69.8% 74.0% |
|TERMINAL (d) | 11/20 (55%) 14/21 (67%) |
|FIRST INCIDENCE | 360 360 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.298 |
|POLY 3 | P=0.416 |
|POLY 1.5 | P=0.424 |
|POLY 6 | P=0.386 |
|LOGISTIC REGRESSION| P=0.334 |
|COCH-ARM / FISHERS | P=0.389 |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|Mammary Gland |
| Fibroma, Fibroadenoma, Carcinoma, or Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # |
|----------- | |
|OVERALL (a) | 37/50 (74%) 34/51 (67%) |
|POLY-3 RATE (b) | 37/44.76 34/45.62 |
|POLY-3 PERCENT (g) | 82.7% 74.5% |
|TERMINAL (d) | 14/20 (70%) 14/21 (67%) |
|FIRST INCIDENCE | 245 79 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.490N |
|POLY 3 | P=0.233N |
|POLY 1.5 | P=0.213N |
|POLY 6 | P=0.290N |
|LOGISTIC REGRESSION| P=0.306N |
|COCH-ARM / FISHERS | P=0.278N |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
Date: 02/09/04 EXPERIMENT: 96021 TEST: 01 Page 6
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 105 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|Pituitary Gland: Pars Distalis or Unspecified Site |
| Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 23/50 (46%) 11/50 (22%) |
|POLY-3 RATE (b) | 23/39.65 11/34.40 |
|POLY-3 PERCENT (g) | 58.0% 32.0% |
|TERMINAL (d) | 14/20 (70%) 7/21 (33%) |
|FIRST INCIDENCE | 437 486 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.014N* |
|POLY 3 | P=0.017N* |
|POLY 1.5 | P=0.011N* |
|POLY 6 | P=0.028N* |
|LOGISTIC REGRESSION| P=0.019N* |
|COCH-ARM / FISHERS | P=0.010N* |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|Pituitary Gland: Pars Distalis or Unspecified Site |
| Carcinoma or Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 24/50 (48%) 12/50 (24%) |
|POLY-3 RATE (b) | 24/40.16 12/34.62 |
|POLY-3 PERCENT (g) | 59.8% 34.7% |
|TERMINAL (d) | 14/20 (70%) 7/21 (33%) |
|FIRST INCIDENCE | 437 486 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.019N* |
|POLY 3 | P=0.021N* |
|POLY 1.5 | P=0.013N* |
|POLY 6 | P=0.035N* |
|LOGISTIC REGRESSION| P=0.020N* |
|COCH-ARM / FISHERS | P=0.011N* |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
Date: 02/09/04 EXPERIMENT: 96021 TEST: 01 Page 7
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 105 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|Skin |
| Fibroma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # |
|----------- | |
|OVERALL (a) | 2/50 (4%) 0/51 (0%) |
|POLY-3 RATE (b) | 2/37.14 0/33.11 |
|POLY-3 PERCENT (g) | 5.4% 0.0% |
|TERMINAL (d) | 1/20 (5%) 0/21 (0%) |
|FIRST INCIDENCE | 452 --- |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.239N |
|POLY 3 | P=0.278N |
|POLY 1.5 | P=0.256N |
|POLY 6 | P=0.300N |
|LOGISTIC REGRESSION| P=0.226N |
|COCH-ARM / FISHERS | P=0.243N |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|Skin |
| Fibroma, Fibrosarcoma, Sarcoma, Myxoma, Myxosarcoma, |
| or Fibrous Histiocytoma |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # |
|----------- | |
|OVERALL (a) | 7/50 (14%) 0/51 (0%) |
|POLY-3 RATE (b) | 7/38.88 0/33.11 |
|POLY-3 PERCENT (g) | 18.0% 0.0% |
|TERMINAL (d) | 2/20 (10%) 0/21 (0%) |
|FIRST INCIDENCE | 183 --- |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.014N* |
|POLY 3 | P=0.014N* |
|POLY 1.5 | P=0.011N* |
|POLY 6 | P=0.020N* |
|LOGISTIC REGRESSION| P=0.007N** |
|COCH-ARM / FISHERS | P=0.006N** |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
Date: 02/09/04 EXPERIMENT: 96021 TEST: 01 Page 8
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 105 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|Skin |
| Fibrosarcoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # |
|----------- | |
|OVERALL (a) | 4/50 (8%) 0/51 (0%) |
|POLY-3 RATE (b) | 4/37.78 0/33.11 |
|POLY-3 PERCENT (g) | 10.6% 0.0% |
|TERMINAL (d) | 1/20 (5%) 0/21 (0%) |
|FIRST INCIDENCE | 183 --- |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.072N |
|POLY 3 | P=0.083N |
|POLY 1.5 | P=0.072N |
|POLY 6 | P=0.096N |
|LOGISTIC REGRESSION| P=0.053N |
|COCH-ARM / FISHERS | P=0.056N |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|Skin |
| Fibrosarcoma, Sarcoma, Myxosarcoma, or Fibrous Histiocytoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # |
|----------- | |
|OVERALL (a) | 5/50 (10%) 0/51 (0%) |
|POLY-3 RATE (b) | 5/38.11 0/33.11 |
|POLY-3 PERCENT (g) | 13.1% 0.0% |
|TERMINAL (d) | 1/20 (5%) 0/21 (0%) |
|FIRST INCIDENCE | 183 --- |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.044N* |
|POLY 3 | P=0.046N* |
|POLY 1.5 | P=0.038N* |
|POLY 6 | P=0.057N |
|LOGISTIC REGRESSION| P=0.028N* |
|COCH-ARM / FISHERS | P=0.027N* |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
Date: 02/09/04 EXPERIMENT: 96021 TEST: 01 Page 9
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 105 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|Thyroid Gland: C-Cell |
| Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 18/49 (37%) 7/51 (14%) |
|POLY-3 RATE (b) | 18/37.75 7/33.34 |
|POLY-3 PERCENT (g) | 47.7% 21.0% |
|TERMINAL (d) | 11/20 (55%) 6/21 (29%) |
|FIRST INCIDENCE | 437 668 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.010N* |
|POLY 3 | P=0.014N* |
|POLY 1.5 | P=0.009N** |
|POLY 6 | P=0.023N* |
|LOGISTIC REGRESSION| P=0.017N* |
|COCH-ARM / FISHERS | P=0.007N** |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|Thyroid Gland: C-Cell |
| Carcinoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 3/49 (6%) 0/51 (0%) |
|POLY-3 RATE (b) | 3/36.14 0/33.11 |
|POLY-3 PERCENT (g) | 8.3% 0.0% |
|TERMINAL (d) | 1/20 (5%) 0/21 (0%) |
|FIRST INCIDENCE | 669 --- |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.143N |
|POLY 3 | P=0.140N |
|POLY 1.5 | P=0.125N |
|POLY 6 | P=0.158N |
|LOGISTIC REGRESSION| P=0.138N |
|COCH-ARM / FISHERS | P=0.114N |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
Date: 02/09/04 EXPERIMENT: 96021 TEST: 01 Page 10
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 105 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|Thyroid Gland: C-Cell |
| Carcinoma or Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 19/49 (39%) 7/51 (14%) |
|POLY-3 RATE (b) | 19/37.90 7/33.34 |
|POLY-3 PERCENT (g) | 50.1% 21.0% |
|TERMINAL (d) | 11/20 (55%) 6/21 (29%) |
|FIRST INCIDENCE | 437 668 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.007N** |
|POLY 3 | P=0.008N** |
|POLY 1.5 | P=0.005N** |
|POLY 6 | P=0.014N* |
|LOGISTIC REGRESSION| P=0.010N* |
|COCH-ARM / FISHERS | P=0.004N** |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|Thyroid Gland: Follicular Cell |
| Adenoma |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | |
|----------- | |
|OVERALL (a) | 2/49 (4%) 0/51 (0%) |
|POLY-3 RATE (b) | 2/35.75 0/33.11 |
|POLY-3 PERCENT (g) | 5.6% 0.0% |
|TERMINAL (d) | 2/20 (10%) 0/21 (0%) |
|FIRST INCIDENCE | 731 (T) --- |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.226N |
|POLY 3 | P=0.264N |
|POLY 1.5 | P=0.245N |
|POLY 6 | P=0.283N |
|LOGISTIC REGRESSION| (e) |
|COCH-ARM / FISHERS | P=0.238N |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
Date: 02/09/04 EXPERIMENT: 96021 TEST: 01 Page 11
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 105 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|Uterus |
| Polyp Stromal |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # |
|----------- | |
|OVERALL (a) | 4/50 (8%) 2/51 (4%) |
|POLY-3 RATE (b) | 4/37.16 2/33.11 |
|POLY-3 PERCENT (g) | 10.8% 6.0% |
|TERMINAL (d) | 1/20 (5%) 2/21 (10%) |
|FIRST INCIDENCE | 624 731 (T) |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.375N |
|POLY 3 | P=0.401N |
|POLY 1.5 | P=0.366N |
|POLY 6 | P=0.440N |
|LOGISTIC REGRESSION| P=0.390N |
|COCH-ARM / FISHERS | P=0.329N |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|Vagina |
| Schwannoma Malignant |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # |
|----------- | |
|OVERALL (a) | 0/50 (0%) 3/51 (6%) |
|POLY-3 RATE (b) | 0/36.38 3/34.55 |
|POLY-3 PERCENT (g) | 0.0% 8.7% |
|TERMINAL (d) | 0/20 (0%) 1/21 (5%) |
|FIRST INCIDENCE | --- 442 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.119 |
|POLY 3 | P=0.111 |
|POLY 1.5 | P=0.115 |
|POLY 6 | P=0.108 |
|LOGISTIC REGRESSION| P=0.133 |
|COCH-ARM / FISHERS | P=0.125 |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
Date: 02/09/04 EXPERIMENT: 96021 TEST: 01 Page 12
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 105 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|All Organs |
| Benign Tumors |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # |
|----------- | |
|OVERALL (a) | 44/50 (88%) 40/51 (78%) |
|POLY-3 RATE (b) | 44/45.72 40/45.55 |
|POLY-3 PERCENT (g) | 96.2% 87.8% |
|TERMINAL (d) | 19/20 (95%) 18/21 (86%) |
|FIRST INCIDENCE | 360 360 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.447N |
|POLY 3 | P=0.105N |
|POLY 1.5 | P=0.087N |
|POLY 6 | P=0.168N |
|LOGISTIC REGRESSION| P=0.204N |
|COCH-ARM / FISHERS | P=0.154N |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|All Organs |
| Malignant Tumors |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # |
|----------- | |
|OVERALL (a) | 23/50 (46%) 12/51 (24%) |
|POLY-3 RATE (b) | 23/43.60 12/38.88 |
|POLY-3 PERCENT (g) | 52.8% 30.9% |
|TERMINAL (d) | 7/20 (35%) 3/21 (14%) |
|FIRST INCIDENCE | 183 79 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.058N |
|POLY 3 | P=0.033N* |
|POLY 1.5 | P=0.023N* |
|POLY 6 | P=0.046N* |
|LOGISTIC REGRESSION| P=0.009N** |
|COCH-ARM / FISHERS | P=0.015N* |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
Date: 02/09/04 EXPERIMENT: 96021 TEST: 01 Page 13
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY) - TOXIC EQUIVALENCY FACTOR EVALUATION (
Terminal Sacrifice at 105 weeks
|=================================================================================================================================|
| | |
| | Females |
|Dose | 3000 UG/ 3000 |
| | KG STOP UG/KG |
|=================================================================================================================================|
| |
|All Organs |
| Malignant and Benign Tumors |
| |
| |
|---------------------------------------------------------------------------------------------------------------------------------|
|TUMOR RATES | # # |
|----------- | |
|OVERALL (a) | 49/50 (98%) 48/51 (94%) |
|POLY-3 RATE (b) | 49/50.00 48/50.33 |
|POLY-3 PERCENT (g) | 98.0% 95.4% |
|TERMINAL (d) | 19/20 (95%) 19/21 (91%) |
|FIRST INCIDENCE | 183 79 |
|-------------------| |
|STATISTICAL TESTS | |
|-------------------| |
|LIFE TABLE | P=0.484 |
|POLY 3 | P=0.427N |
|POLY 1.5 | P=0.378N |
|POLY 6 | P=0.475N |
|LOGISTIC REGRESSION| P=0.277N |
|COCH-ARM / FISHERS | P=0.316N |
|ORDER RESTRICTED | (e) |
|=================================================================================================================================|
(a) Number of tumor-bearing animals / number of animals examined at site.
(b) Number of tumor-bearing animals / Poly-3 number
(d) Observed incidence at terminal kill.
(f) Beneath the control incidence are the P-values associated with the trend
test. Beneath the dosed group incidence are the P-values corresponding to
pairwise comparisons between the controls and that dosed group. The life
table analysis regards tumors in animals dying prior to terminal kill as
being (directly or indirectly) the cause of death.
Logistic regression is an alternative
method for analyzing the incidence of non-fatal tumors. The Cochran-Armitage
and Fishers exact tests compare directly the overall incidence rates
For all tests a negative trend is indicated by N
(e) Value of Statistic cannot be computed.
(g) Poly-3 adjusted lifetime tumor incidence.
(I) Interim sacrifice
(T) Terminal sacrifice
# Tumor rates based on number of animals necropsied.
* To the right of any statistical result, indicates significance at (P<=0.05).
** To the right of any statistical result, indicates significance at (P<=0.01).